Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CardiolRx in acute myocarditis
MOH_2022-02-24_010426Phase 2Completed
- Sponsor
- Cardiol Therapeutics Inc.
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in acute myocarditis (2 arms), sponsored by Cardiol Therapeutics Inc. Started Feb 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on MOH_2022-02-24_010426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-02-24_010426.